Susquehanna International Group’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-196,827
Closed -$2.17M 13669
2025
Q4
$1.58M Buy
+196,827
New +$4.6M ﹤0.01% 6130
2025
Q2
Sell
-10,372
Closed -$181K 13240
2025
Q1
$181K Buy
+10,372
New +$308K ﹤0.01% 11052
2024
Q2
Sell
-11,276
Closed -$1.01M 12702
2024
Q1
$1.01M Buy
+11,276
New +$615K ﹤0.01% 6885
2023
Q4
Sell
-240
Closed -$4.39K 12865
2023
Q3
$4.39K Hold
240
﹤0.01% 11804
2023
Q2
$4.15K Sell
240
-1,906
-89% -$37K ﹤0.01% 11839
2023
Q1
$54K Buy
2,146
+781
+57% +$89K ﹤0.01% 11673
2022
Q4
$263K Buy
1,365
+225
+20% +$23.1K ﹤0.01% 9428
2022
Q3
$102K Sell
1,140
-644
-36% -$65.4K ﹤0.01% 11689
2022
Q2
$134K Buy
1,784
+1,404
+369% +$94.9K ﹤0.01% 11166
2022
Q1
$40K Buy
+380
New +$72.6K ﹤0.01% 12402
2021
Q2
Sell
-2,595
Closed -$1.27M 12943
2021
Q1
$1.23M Buy
2,595
+2,455
+1,754% +$4.77M ﹤0.01% 7167
2020
Q4
$248K Sell
140
-87
-38% -$115K ﹤0.01% 9663
2020
Q3
$218K Buy
+227
New +$244K ﹤0.01% 9317

Other funds holding KRRO

Susquehanna International Group's KRRO Position: Q1 2026 in Review

Susquehanna International Group sold out of Korro Bio (KRRO) in Q1 2026, closing a stake of 196,827 shares — an estimated $2.17M sold.

Susquehanna International Group first reported a position in KRRO in Q3 2020 and held it in 13 quarters. The position peaked at $1.58M in Q4 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Susquehanna International Group reported no remaining Korro Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 196,827 Korro Bio shares in Q1 2026, an estimated $2.17M.
  • Susquehanna International Group first reported a position in Korro Bio in Q3 2020 and held it in 13 quarters.
  • Susquehanna International Group's Korro Bio position peaked at $1.58M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.